Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket

February 19, 2020 updated by: Donna Berry, PhD, RN, FAAN, AOCN, Dana-Farber Cancer Institute

Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket: Randomized Trial

This research study is studying a garment called the Jacki® recovery jacket that can be worn after surgery as a possible way to manage pain from surgical drains.

The study intervention involved in this study is:

-"Jacki" recovery jacket

Study Overview

Detailed Description

In this research study, the investigators are studying the Jacki, a garment that can be worn post-mastectomy with pockets that hold post-surgical drains. The Jacki was invented by a cancer survivor who leads A Little Easier Recovery®, a non-profit organization in Massachusetts, and may help participants manage the pain of post-surgical drains to increase comfort and ease of daily living. The jacket has not previously been tested in a research study. The investigators are hoping to learn whether the jacket is effective in reducing pain and discomfort from the time participants leave the hospital until they return to have their drains removed.

Study Type

Interventional

Enrollment (Actual)

139

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Dana Farber Cancer Institute
      • Boston, Massachusetts, United States, 02130
        • Brigham and Women's Faulkner Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients who are ≥ 18 years old.
  • Patients who speak and understand English.
  • Patients who have had mastectomy with reconstructive surgery in one or both breasts.

Exclusion Criteria:

  • Co-morbid delirium
  • Dementia
  • Mental illness, or neurocognitive deficit prohibiting informed consent and/or ability to complete study procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Standard Care
-Standard Care pain medicine/management will be given
Standard care pain medicine and management in hospitals where the study enrolls
Experimental: JACKI® RECOVERY JACKET + Standard Care
  • Patient will be encouraged to use the Jacki Recovery Jacket at home
  • Patient will be taught how to tuck the drainage tubes in the jacket pocket
  • Patient will be taught how to un-tuck the drainage tubes from jacket pocket
  • Standard care pain medicine/management will be given
Standard care pain medicine and management in hospitals where the study enrolls
An outer jacket that holds surgical drains and allows access for blood draws

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity (on the 0-10 Pain Intensity Numeric Scale)
Time Frame: 1-2 weeks
Pain Intensity Numeric Scale (0-10)(higher scores = worse outcome)
1-2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptom Distress Scale - Pain Frequency
Time Frame: 1-2 weeks
1 item (score range 1-5); higher score = worse outcome
1-2 weeks
Symptom Distress Scale - Pain Intensity
Time Frame: 1-2 weeks
1 item (score range 1-5); higher score = worse outcome
1-2 weeks
PROMIS Pain Intensity Scale (Short Form 3a)
Time Frame: 1-2 weeks
3 items (T score 0-100); higher score = worse outcome
1-2 weeks
PROMIS Pain Interference Scale - Short Form 8a
Time Frame: 1-2 weeks
8 items (T score 0-100); higher score = worse outcome
1-2 weeks
EORTC QLQ-C30: Global QOL Scale
Time Frame: 1-2 weeks
2 items; score range 0-100 (higher score = better outcome)
1-2 weeks
EORTC QLQ-C30: Physical Functioning Scale
Time Frame: 1-2 weeks
5 items; score range 0-100 (higher score = better outcome)
1-2 weeks
EORTC QLQ-C30: Role Functioning Scale
Time Frame: 1-2 weeks
2 items; score range 0-100 (higher score = better outcome)
1-2 weeks
EORTC QLQ-C30: Emotional Functioning Scale
Time Frame: 1-2 weeks
4 items; score range 0-100 (higher score = better outcome)
1-2 weeks
EORTC QLQ-C30: Cognitive Functioning Scale
Time Frame: 1-2 weeks
2 items; score range 0-100 (higher score = better outcome)
1-2 weeks
EORTC QLQ-C30: Social Functioning Scale
Time Frame: 1-2 weeks
2 items; score range 0-100 (higher score = better outcome)
1-2 weeks
EORTC QLQ-BR23: Body Image Subscale
Time Frame: 1-2 weeks
4 items (score 0-100); higher score = worse outcome
1-2 weeks
EORTC QLQ-BR23: Sexual Functioning Subscale
Time Frame: 1-2 weeks
2 items (range 0-100); higher score = better outcome
1-2 weeks
EORTC QLQ-BR23: Sexual Enjoyment Subscale
Time Frame: 1-2 weeks
1 item (range 0-100); higher score = better outcome
1-2 weeks
EORTC QLQ-BR23: Future Perspective Subscale
Time Frame: 1-2 weeks
1 item (range 0-100); higher score = worse outcome
1-2 weeks
EORTC QLQ-BR23: Systemic Therapy Side Effects Subscale
Time Frame: 1-2 weeks
7 items (range 0-100); higher score = worse outcome
1-2 weeks
EORTC QLQ-BR23: Breast Symptoms Subscale
Time Frame: 1-2 weeks
4 items (range 0-100); higher score = worse outcome
1-2 weeks
EORTC QLQ-BR23: Arm Symptoms Subscale
Time Frame: 1-2 weeks
3 items (range 0-100); higher score = worse outcome
1-2 weeks
EORTC QLQ-BR23: Upset by Hair Loss Subscale
Time Frame: 1-2 weeks
1 item (range 0-100); higher score = worse outcome
1-2 weeks
Pain Patterns At Home: Average Daily Pain Intensity (Daily Diary)
Time Frame: 1 week
Average 0-10 Pain Intensity Numeric Scale Rating, for 7 days post-discharge, if at least 5 days reported (T2 diary)
1 week
Pain Management At Home: Use of Pain Medication (Daily Diary)
Time Frame: 1-2 weeks
Participant self-report of average daily morphine eqivalent dose taken in first 7 days post-discharge (if at least 5 days reported)
1-2 weeks
Pain Management At Home: Use of Mastectomy Bra (Daily Diary)
Time Frame: 1-2 weeks
Self-reported proportion of days in the first 7 days post discharge that participant wore a mastectomy bra (if at least 5 days reported)
1-2 weeks
Pain Management At Home: Use of Mastectomy Camisole (Daily Diary)
Time Frame: 1-2 weeks
Self-reported proportion of days in the first 7 days post discharge that participant wore a mastectomy camisole (if at least 5 days reported)
1-2 weeks
Patient-Reported Usage of Jacki Recovery Jacket (Daily Diary)
Time Frame: 1-2 weeks
Self-reported proportion of days in the first 7 days post-discharge that participant wore the Jacki recovery jacket at all; no score is better or worse
1-2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Donna Berry, PhD, RN, Dana-Farber Cancer Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2017

Primary Completion (Actual)

January 11, 2018

Study Completion (Actual)

January 11, 2018

Study Registration Dates

First Submitted

November 18, 2016

First Submitted That Met QC Criteria

November 28, 2016

First Posted (Estimate)

November 29, 2016

Study Record Updates

Last Update Posted (Actual)

March 12, 2020

Last Update Submitted That Met QC Criteria

February 19, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mastectomy

Clinical Trials on Standard Care Pain medicine/management

3
Subscribe